These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16441232)

  • 21. Anti-obesity effect of total phenylpropanoid glycosides from Ligustrum robustum Blume in fatty diet-fed mice via up-regulating leptin.
    Yang RM; Liu F; He ZD; Ji M; Chu XX; Kang ZY; Cai DY; Gao NN
    J Ethnopharmacol; 2015 Jul; 169():459-65. PubMed ID: 25576894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brown adipose tissue: a potential target in the fight against obesity and the metabolic syndrome.
    Poekes L; Lanthier N; Leclercq IA
    Clin Sci (Lond); 2015 Dec; 129(11):933-49. PubMed ID: 26359253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PAI-1 inhibition in obesity and the metabolic syndrome: a promising therapeutic strategy.
    Schalkwijk CG; Stehouwer CD
    Thromb Haemost; 2006 Dec; 96(6):698-9. PubMed ID: 17139361
    [No Abstract]   [Full Text] [Related]  

  • 24. Targeting energy expenditure in muscle as a means of combating obesity.
    Clarke IJ; Henry BA
    Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):121-4. PubMed ID: 19650796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostacyclin: A major prostaglandin in the regulation of adipose tissue development.
    Rahman MS
    J Cell Physiol; 2019 Apr; 234(4):3254-3262. PubMed ID: 30431153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An update in the management of obesity: the weight of CNS targets.
    Bariohay B; Roux JA; Bonnet MS; Dallaporta M; Troadec JD
    Recent Pat CNS Drug Discov; 2011 Sep; 6(3):164-80. PubMed ID: 21834783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging drugs for obesity: linking novel biological mechanisms to pharmaceutical pipelines.
    Correia ML; Haynes WG
    Expert Opin Emerg Drugs; 2005 Aug; 10(3):643-60. PubMed ID: 16083333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacotherapy of obesity.
    Hofbauer KG; Nicholson JR
    Exp Clin Endocrinol Diabetes; 2006 Oct; 114(9):475-84. PubMed ID: 17115344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological approaches for the treatment of obesity.
    Fernández-López JA; Remesar X; Foz M; Alemany M
    Drugs; 2002; 62(6):915-44. PubMed ID: 11929339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EJE PRIZE 2017: Hypothalamic AMPK: a golden target against obesity?
    López M
    Eur J Endocrinol; 2017 May; 176(5):R235-R246. PubMed ID: 28232370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Latest approaches for the treatment of obesity.
    Jackson VM; Breen DM; Fortin JP; Liou A; Kuzmiski JB; Loomis AK; Rives ML; Shah B; Carpino PA
    Expert Opin Drug Discov; 2015; 10(8):825-39. PubMed ID: 25967138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripheral targets in obesity treatment: a comprehensive update.
    Chatzigeorgiou A; Kandaraki E; Papavassiliou AG; Koutsilieris M
    Obes Rev; 2014 Jun; 15(6):487-503. PubMed ID: 24612276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peroxisome proliferator-activated receptors as attractive antiobesity targets.
    Zhang F; Lavan B; Gregoire FM
    Drug News Perspect; 2004 Dec; 17(10):661-9. PubMed ID: 15696231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiogenesis and obesity.
    Lijnen HR
    Cardiovasc Res; 2008 May; 78(2):286-93. PubMed ID: 18006485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Viola mandshurica ethanolic extract prevents high-fat-diet-induced obesity in mice by activating AMP-activated protein kinase.
    Sung YY; Kim DS; Kim HK
    Environ Toxicol Pharmacol; 2014 Jul; 38(1):41-50. PubMed ID: 24879516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Modulation of tissue exposure to cortisol, new perspective for reducing the metabolic risk associated with obesity].
    Iovino A; Scheen AJ
    Rev Med Liege; 2010 Mar; 65(3):140-6. PubMed ID: 20411818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The obesity epidemic: current and future pharmacological treatments.
    Hofbauer KG; Nicholson JR; Boss O
    Annu Rev Pharmacol Toxicol; 2007; 47():565-92. PubMed ID: 17002599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-Obesity Effect of Chitosan Oligosaccharide Capsules (COSCs) in Obese Rats by Ameliorating Leptin Resistance and Adipogenesis.
    Pan H; Fu C; Huang L; Jiang Y; Deng X; Guo J; Su Z
    Mar Drugs; 2018 Jun; 16(6):. PubMed ID: 29874843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel treatments for obesity and osteoporosis: targeting apoptotic pathways in adipocytes.
    Nelson-Dooley C; Della-Fera MA; Hamrick M; Baile CA
    Curr Med Chem; 2005; 12(19):2215-25. PubMed ID: 16178781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.